2nd October 2017:
Weybridge, UK: Today, Veriton Pharma Ltd is announced as the new company name for Special Products Ltd.
This name change has occurred both to incorporate the company’s past heritage with its future ambitions to make trusted medicines available for everyday living.
The Chief Commercial Officer commented: “With the launch of Epistatus® 10mg in 1mL Oromucosal Solution Midazolam (as maleate), on the 8th of September 2017, and our extensive range of existing unlicensed medicines, we would like to assure our customers and partners that the excellent service and quality they have come to expect from us as a company will continue and all contacts at the company will remain the same.”
With its legacy of technical expertise, which began in a world-renowned children’s hospital over 20 years ago, Veriton Pharma sources and supplies licensed medicines for CNS and over 75 high-quality, UK batch manufactured unlicensed medicines in the fields of epilepsy, neurology and rare paediatric conditions that licensed products cannot meet.
Headquartered in Weybridge, UK, Veriton Pharma, is a privately owned, speciality pharmaceutical company, which also has regional offices in the Middle East and Australia.
For media enquiries please contact Helen Lawn & Associates. Telephone 01892 525141 / 07879 818247 or email@example.com
Notes to Editors:
For further information about Veriton Pharma, visit www.veritonpharma.com
For comment and interviews, please contact Helen Lawn & Associates Ltd.
Epistatus® prescribing information can be found here.
Date of preparation August 2017.